BioLineRx (BLRX) Gross Profit: 2023-2025
Historic Gross Profit for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to $232,000.
- BioLineRx's Gross Profit fell 94.84% to $232,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $10.2 million, marking a year-over-year increase of 4.42%. This contributed to the annual value of $19.7 million for FY2024, which is 1675.90% up from last year.
- Per BioLineRx's latest filing, its Gross Profit stood at $232,000 for Q2 2025, which was up 4.98% from $221,000 recorded in Q1 2025.
- In the past 5 years, BioLineRx's Gross Profit registered a high of $5.7 million during Q4 2024, and its lowest value of -$932,000 during Q4 2023.
- For the 3-year period, BioLineRx's Gross Profit averaged around $2.2 million, with its median value being $1.1 million (2023).
- As far as peak fluctuations go, BioLineRx's Gross Profit soared by 707.30% in 2024, and later tumbled by 95.91% in 2025.
- BioLineRx's Gross Profit (Quarterly) stood at -$932,000 in 2023, then surged by 707.30% to $5.7 million in 2024, then slumped by 94.84% to $232,000 in 2025.
- Its Gross Profit was $232,000 in Q2 2025, compared to $221,000 in Q1 2025 and $5.7 million in Q4 2024.